Search result for Bios
Global Acid-Based Biostimulants Market is Projected to Reach US$ 3.2 Bn by 2030, Growing at an Estimated CAGR of 25% over the Forecast Period
Productivity is the key in any sort of business and this remains true even in the case of agriculture. Each passing day, new and smarter ways of farming are being sought. Use of acid-based biostimulants is rapidly gaining popularity owing to amount of productivity linked to it. Biostimulants prim...
CATALENT ACQUIRES A SUBSIDIARY OF PROMETHERA BIOSCIENCES
HIGHLIGHTS
- Catalent has acquired a subsidiary of Promethera Biosciences.
- Catalent is growing its operations in Europe.
- This is the third acquisition by Catalent in Belgium.
The Somerset-based Catalent is growing in Europe....
COVID-19 SELF-TEST KITS GIVEN CONDITIONAL APPROVAL IN S. KOREA
Highlights –
- COVID-19 self-test kits given conditional approval in S. Korea.
- The test kits are developed by two biotech firms, SD Biosensor and Humasis.
- The tool however has a low accuracy rate compared to PCR tests.
- The te...
CHINA DEVELOPED mRNA VACCINE LIKELY TO START TRIALS NEXT MONTH
Highlights –
- China developed mRNA vaccine likely to start trials next month.
- The vaccine candidate ARCoV is said to be the furthest along the clinical trial process at present.
- The vaccine may get overseas approval to conduct Phase II...
SOFTBANK TO INVEST $900 MILLION IN US-BASED PACIFIC BIOSCIENCES OF CALIFORNIA
Highlights
• SoftBank Group has decided to invest $900 million in a US developer of equipment for genetic analysis
• This investment comes as billionaire Masayoshi Son’s SoftBank Group is looking to diversify its portfolio and mainly US listed companies
...
S. KOREA DRUG SAFETY AGENCY APPROVES ASTRAZENECA’S COVID-19 VACCINE
Highlights –
- S. Korea's drug safety agency approves AstraZeneca’s COVID-19 vaccine.
- AstraZeneca’s vaccine has been approved to be used for people aged 65 and older.
- AstraZeneca will start delivering the first batch of ...
‘BIOS’ STARRING TOM HANKS POSTPONED TO AUGUST THIS YEAR
Highlights
• While previously the makers were eyeing October release, the film was then rescheduled to April
• Bios is being helmed by Miguel Sapochnik, best known for his work on Game of Thrones, from an original screenplay penned by Craig Luck
• The ...
SK BIOSCIENCE LOOKING AT AN IPO MONEYSPINNER WITH ASTRAZENECA COVID-19 VACCINE DEAL
- Ever since a deal was reached in July for SK Bioscience to manufacture AstraZeneca's COVID-19 vaccine, the SK subsidiary has already succeeded in producing the vaccine at its Andong L HOUSE vaccine center.
- While some vials of the vaccine produced have already been exported,...
BILL GATES BACKED SK BIOSCIENCE CAN PRODUCE 200 MILLION
Highlights:
• Bill Gates has funded SK BioScience a covid19 vaccine development worth $3.6 million in
• SK Bioscience is also developing its candidates for COVID vaccines
Bill Gates foundation has now donated ...
BILL GATES IN A TETE-A-TETE WITH PRESIDENT MOON
- Microsoft Chairman Bill Gates had a word with President Moon of Korea and in his conversation.
- He lauded President Moon for the efforts taken in the direction for developing a vaccine to combat the COVID-19 pandemic.
He was unduly impressed with the response o...
BILL GATES: SOUTH KOREAN FIRM COULD MAKE 200 MILLION COVID-19 VACCINE KITS BY JUNE
Highlights:
- SK Bioscience, the South Korean pharmaceutical company capable of producing 200 million coronavirus vaccine kits by June 2021.
- The SK Bioscience has received $3.6 million in May by the US Billionaire’s foundation to accelerate the de...
DREAMTECH’S ECG PATCH BIOSENSOR 1A HAS BEEN APPROVED BY THE FDA
Highlights –
- Dreamtech’s ECG patch Biosensor 1A has been approved by the FDA.
- The new sensor is said to work wirelessly in the transmission of ECG and heart rate.
- Dreamtech partnered with American healthcare company LifeSignals...
CELLTRION’S YEAR-END PROFIT, BIOSIMILARS DEMAND AT THE OVERSEAS MARKET
Highlights –
- Pharmaceutical giant Celltrion makes operating profit
- Biosimilars in demand
- Company aims to add 46 more new drugs by 2022
South Korean pharmaceutical giant and leading drug maker Celltrion Inc. ha...
THREE NEW ONCOLOGY BIOSIMILARS INTRODUCED IN US MARKETS
Highlights:
- Bevacizumab-bvzr, rituximab-pvvr, and Trastuzumab-qyyp have been introduced in the United States.
- Pfizer will become the first manufacturer to launch 3 oncology biosimilar products in the US market.
- The 3 antibodies will be avai...
The Nintendo Switch will touch BioShock Collection
The names of BioShock would be a good fit for the Nintendo Switch, which is not as strong as its first-person shooter series, for its great strength. These BioShock games would give the platform a true tonic shot on the arms with the rich stories and solid gameplays that combine arms with a speci...
Korea’s Lemonex recognized as best brand for innovative drug delivery method
An innovative and gen-next drug delivery and biosensor technology has been launched by Lemonex- a global biotherapeutics and bioengineering firm, headquartered in Seoul. With regards to the technology, the firm will be able to develop immune-oncology drugs, gene therapeutics and antibody. L...
Aroa Biosurgery
Aroa Biosurgery Limited (Aroa), a New Zealand-headquartered, secretly held delicate tissue fix organization has designated exceptionally experienced Australia-based, Non-official Director, John Diddams to its Board. Aroa Chair, Jim Mclean says Mr. Diddams' arrangement is opportune as the orga...
Discovery of genes that are active in antidepressant biosynthesis
The herb St John's Wort Hypericum perforatum is a medicinal plant with a long history. The first-century Greek doctors like Hippocrates and Pliny, among other applications, suggested it as a diuretic and as a remedy for snakebites. It was used in magic potions in the Middle Ages to ward off e...
Toxophilite Materials progresses the first-stage model of graphene biosensor
Toxophilite Materials has reported it has advanced its graphene-based biosensor innovation by building a first-stage model gadget. This gadget will test the printing and execution of graphene inks created from the stock of Carbon Allotropes, Archer's entirely claimed auxiliary. Toxophilite is...
insulin biosimilar launched in Australia by biocon, mylan
Bio-technology major Biocon and pharmaceutical firm Mylan N V proclaimed the launch of insulin glargine biosimilar Semglee, indicated for the treatment of diabetes, in Australia.
Semglee is that the 1st insulin glargine biosimilar accessible on the Pharmaceutical advantages theme (PBS) ...